Period End 4/15/02
Table of Contents



SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): April 15, 2002

NUTRACEUTIX, INC.
(Exact name of registrant as specified in its charter)

         
Delaware
(State or other jurisdiction
of incorporation)
  000-24693
(Commission File Number)
  91-1689591
(I.R.S. Employer
Identification No.)
     
8340 154th Avenue NE, Redmond, Washington
(Address of principal executive offices)
  98052
(Zip Code)

Registrant’s telephone number, including area code: (425) 883-9518



 


TABLE OF CONTENTS

Item 5. Other Events.
Item 7. Financial Statements and Exhibits.
SIGNATURES
Exhibit 99


Table of Contents

Item 5. Other Events.

     On April 15, 2002, the registrant issued a press release reporting that Carl W. Schafer had resigned from the Company’s board of directors for personal reasons. The press release is filed herewith as Exhibit 99.

Item 7. Financial Statements and Exhibits.

     (c)  Exhibits.

     The following exhibits are filed herewith and this list constitutes the exhibit index:

     
Exhibit No.   Description

 
99   Nutraceutix, Inc. Press Release, April 15, 2002

SIGNATURES

     Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

             
        NUTRACEUTIX, INC.
 
  Date: 04/25/02       By:/s/David T. Howard    
   
     
            David T. Howard
President and Chief Executive Officer

-2-